Explore the Global Viscosupplementation Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Viscosupplementation Market

Key Insight

Viscosupplementation sales will expand through 2036, with three injection knee hyaluronic acid injections at 47.8% of product demand and ambulatory surgical centers at 32.3% of end user sales in 2026. The market is estimated at USD 2,410.2 million in 2026 and is forecast to record a 5.7% CAGR between 2026 and 2036.

April 10, 2026

Anurag Sharma

324 Pages

Cite this Report

Viscosupplementation Market

https://www.futuremarketinsights.com/reports/viscosupplementation-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Anika Therapeutics
Bioventus LLC
Chugai Pharmaceutical Co. Ltd
Ferring B.V
Fidia Farmaceutici S.p.A
Hanmi Pharm. Co. Ltd
LG Chem Life Sciences Company
OrthogenRx
L'Oréal
Seikagaku Corporation
Zimmer Biomet Holdings

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Viscosupplementation Market

Key Players

Similar Industry Reports